PubMed:15668505 / 101-306 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T2","span":{"begin":0,"end":205},"obj":"Sentence"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-entities","denotations":[{"id":"1411","span":{"begin":76,"end":81},"obj":"SequenceVariant"},{"id":"1412","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"},{"id":"1413","span":{"begin":179,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"db_id","subj":"1411","obj":"DBSNP:rs144848"},{"id":"A6","pred":"db_id","subj":"1412","obj":"NCBIGene:675"},{"id":"A7","pred":"db_id","subj":"1413","obj":"MESH:D001943"},{"id":"A8","pred":"db_id","subj":"1413","obj":"MESH:D010051"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T3","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":198,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0008170"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0004992"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T1","span":{"begin":76,"end":81},"obj":"SequenceVariant"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T5","span":{"begin":39,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":149,"end":153},"obj":"GeneOrGeneProduct"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T3","span":{"begin":39,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":149,"end":153},"obj":"GeneOrGeneProduct"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T2","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D010051"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T2","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T3","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0008170"},{"id":"A4","pred":"mondo_id","subj":"T3","obj":"0005140"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T2","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"ID:","subj":"T2","obj":"D010051"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T2","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"#label","subj":"T2","obj":"D010051"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T2","span":{"begin":89,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T19450","span":{"begin":190,"end":204},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T79781","span":{"begin":76,"end":81},"obj":"SequenceVariant"}],"attributes":[{"id":"A2","pred":"#label","subj":"T19450","obj":"D010051"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}

{"project":"tmVarCorpus","denotations":[{"id":"T1","span":{"begin":76,"end":81},"obj":"ProteinMutation:p|SUB|N|372|H"}],"text":"The HH genotype of the nonconservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3- to 1.5-fold increase in risk of both breast and ovarian cancer."}